0001382963-16-000150.txt : 20160223 0001382963-16-000150.hdr.sgml : 20160223 20160222173505 ACCESSION NUMBER: 0001382963-16-000150 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160223 DATE AS OF CHANGE: 20160222 EFFECTIVENESS DATE: 20160223 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Trethera Corp CENTRAL INDEX KEY: 0001639837 IRS NUMBER: 462817645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-257926 FILM NUMBER: 161446088 BUSINESS ADDRESS: STREET 1: 9350 WILSHIRE BLVD. STREET 2: SUITE 214 CITY: BEVERLY HILLS STATE: CA ZIP: 90212 BUSINESS PHONE: 310-997-2788 MAIL ADDRESS: STREET 1: 9350 WILSHIRE BLVD. STREET 2: SUITE 214 CITY: BEVERLY HILLS STATE: CA ZIP: 90212 FORMER COMPANY: FORMER CONFORMED NAME: Triangle Therapeutics Inc. DATE OF NAME CHANGE: 20150416 D 1 primary_doc.xml X0707 D LIVE 0001639837 Trethera Corp 9350 WILSHIRE BLVD. SUITE 214 BEVERLY HILLS CA CALIFORNIA 90212 310-997-2788 DELAWARE Triangle Therapeutics Inc. Corporation true 2015 Johannes Czernin 9350 Wilshire Blvd. Suite 214 Beverly Hills CA CALIFORNIA 90212 Director Johanna Holldack 9350 Wilshire Blvd. Suite 214 Beverly Hills CA CALIFORNIA 90212 Executive Officer Director Carl W. McKinzie 10900 Wilshire Blvd. Suite 850 Los Angeles CA CALIFORNIA 90024 Executive Officer Director John Stretton 9350 Wilshire Blvd. Suite 214 Beverly Hills CA CALIFORNIA 90212 Executive Officer Nathan Mata 9350 Wilshire Blvd. Suite 214 Beverly Hills CA CALIFORNIA 90212 Executive Officer Jean B. deKernion 9350 Wilshire Blvd. Suite 214 Beverly Hills CA CALIFORNIA 90212 Director Caius Radu 9350 Wilshire Blvd. Suite 214 Beverly Hills CA CALIFORNIA 90212 Director Louis L. Gonda 9350 Wilshire Blvd. Suite 214 Beverly Hills CA CALIFORNIA 90212 Director Biotechnology Decline to Disclose 06b false 2016-02-10 false true true true false 0 10016681 7400453 2616228 This amount includes preferred stock, common stock, warrants and common stock issuable upon conversion of preferred stock/exercise of warrants. false 40 0 0 0 false Trethera Corp /s/Johanna Holldack, M.D. Johanna Holldack, M.D. President and CEO 2016-02-19